Flavivirus nonstructural proteins and replication complexes as antiviral drug targets

K van den Elsen, BLA Chew, JS Ho, D Luo - Current opinion in virology, 2023 - Elsevier
Highlights•Molecular structures and predicated models of flaviviral NS proteins.•Recent
advance in antiviral development targeting NS proteins.•Inhibitors targeting NS4B entering …

Inhibitors of the Zika virus protease NS2B-NS3

S Voss, C Nitsche - Bioorganic & medicinal chemistry letters, 2020 - Elsevier
In recent years, the Zika virus has emerged from a neglected flavivirus to a health-
threatening pathogen that causes epidemic outbreaks associated with neurological …

Antiviral agents against flavivirus protease: prospect and future direction

SK Samrat, J Xu, Z Li, J Zhou, H Li - Pathogens, 2022 - mdpi.com
Flaviviruses cause a significant amount of mortality and morbidity, especially in regions
where they are endemic. A recent example is the outbreak of Zika virus throughout the …

Structure-based optimization and characterization of macrocyclic Zika virus NS2B-NS3 protease inhibitors

S Huber, NJ Braun, LC Schmacke… - Journal of Medicinal …, 2022 - ACS Publications
Zika virus (ZIKV) is a human pathogenic arbovirus. So far, neither a specific treatment nor a
vaccination against ZIKV infections has been approved. Starting from our previously …

Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease

S Nie, J Zhao, X Wu, Y Yao, F Wu, YL Lin, X Li… - European journal of …, 2021 - Elsevier
Zika virus belongs to the Flavivirus family of RNA viruses, which include other important
human pathogens such as dengue and West Nile virus. There are no approved antiviral …

NS2B‐NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review

DAF Nunes, FRS Santos… - Journal of Medical …, 2022 - Wiley Online Library
Zika virus (ZIKV) infections are associated with severe neurological complications and are a
global public health concern. There are no approved vaccines or antiviral drugs to inhibit …

Recent advances in the study of zika virus structure, drug targets, and inhibitors

Y Feng - Frontiers in Pharmacology, 2024 - frontiersin.org
Zika Virus (ZIKV) is a positive-strand RNA virus that can lead to Guillain-Barré syndrome or
encephalitis in some individuals and hence presents a serious public health risk. Since the …

[HTML][HTML] The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach

MU Mirza, I Alanko, M Vanmeert, KM Muzzarelli… - European Journal of …, 2022 - Elsevier
With expanding recent outbreaks and a lack of treatment options, the Zika virus (ZIKV) poses
a severe health concern. The availability of ZIKV NS2B-NS3 co-crystallized structures paved …

Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays

LH Santos, REO Rocha, DL Dias, BMRM Ribeiro… - Pharmaceuticals, 2023 - mdpi.com
The NS2B-NS3 protease (NS2B-NS3pro) is regarded as an interesting molecular target for
drug design, discovery, and development because of its essential role in the Zika virus …

[HTML][HTML] Carbazole to indolazepinone scaffold morphing leads to potent cell-active dengue antivirals

V Zogali, D Kiousis, S Voutyra, G Kalyva… - European Journal of …, 2024 - Elsevier
According to WHO, dengue virus is classed among major threats for future pandemics and
remains at large an unmet medical need as there are currently no relevant antiviral drugs …